Dynavax Technologies | Capital Social E Reservas

Equity Capital And Reserves Alterar Data
AbbVie USD 8.05B 4.05B 2024-03
Adma Biologics USD 153.71M 18.5M 2024-03
Amgen USD 5.02B 1.21B 2024-03
AstraZeneca USD 37.5B 1.64B 2024-03
Biogen USD 15.21B 413.6M 2024-03
BioMarin Pharmaceutical USD 5.07B 122.27M 2024-03
Bristol-Myers Squibb USD 16.55B 12.45B 2024-03
Dynavax Technologies USD 618.48M 3.59M 2024-03
Gilead Sciences USD 17.46B 5.29B 2024-03
Glaxosmithkline GBP 13.23B 118M 2024-03
Merck USD 40.42B 822M 2024-03
Neurocrine Biosciences USD 2.39B 384M 2024-03
Novartis USD 39.76B 6.91B 2024-03
Pfizer USD 92.56B 4.38B 2024-03
Regeneron Pharmaceuticals USD 26.99B 1.02B 2024-03
Roche Holding CHF 29.32B 2.8B 2023-12
Sarepta Therapeutics USD 961.19M 196.83M 2024-03
TG Therapeutics USD 160.11M 393K 2024-03
Vertex Pharmaceuticals USD 18.55B 2.03B 2024-03



Dynavax Technologies Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.